Optical control of pain in vivo with a photoactive mGlu5 receptor negative allosteric modulator

Autor: Marc López-Cano, Jean-Philippe Pin, Paola Di Pietro, Giuseppe Battaglia, Francisco Ciruela, Pamela Scarselli, Xavier Rovira, Joan Font, Amadeu Llebaria, Cyril Goudet, Jesús Giraldo, Serena Notartomaso, Víctor Fernández-Dueñas, Roger Bresolí-Obach, Juan Lorenzo Catena, Ferdinando Nicoletti, Fanny Malhaire, Santi Nonell
Přispěvatelé: Universitat Ramon Llull. IQS, Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), Institute for Advanced Chemistry of Catalonia, Universitat Autònoma de Barcelona (UAB), Universitat de Barcelona (UB), Istituto Neurologico Mediterraneo (NEUROMED I.R.C.C.S.), Università degli Studi di Roma 'La Sapienza' = Sapienza University [Rome] (UNIROMA)-University of Naples Federico II = Università degli studi di Napoli Federico II, Universitat Ramon Llull [Barcelona] (URL), Institut de Génomique Fonctionnelle (IGF), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Instituto de Salud Carlos III [Madrid] (ISC), Università degli Studi di Roma 'La Sapienza' = Sapienza University [Rome] (UNIROMA), Goudet, Cyril, Universitat de Barcelona
Rok vydání: 2017
Předmět:
0301 basic medicine
Life Sciences & Biomedicine - Other Topics
Pharmacology
neuroscience
0302 clinical medicine
Light-operated drugs
Malalties cròniques
Neurociències
Pain treatment
Biology (General)
BRAIN
Receptor
allosteric modulation
Chemistry
METABOTROPIC GLUTAMATE RECEPTORS
General Neuroscience
genetics and molecular biology (all)
Glutamate receptor
Chronic pain
DORSAL-HORN NEURONS
analgesia
General Medicine
Raseglurant
3. Good health
ANIMAL-MODELS
Medicine
[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]
mGlu5
Complex diseases
Life Sciences & Biomedicine
Farmacologia
Allosteric modulator
DIFFERENTIAL ROLES
QH301-705.5
Ratolins (Animals de laboratori)
Science
Allosteric regulation
Optical control
MGLUR5
General Biochemistry
Genetics and Molecular Biology

MECHANISMS
03 medical and health sciences
Tractament del dolor
In vivo
TARGETS
medicine
biochemistry
[SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]
Analgèsia
medicine (all)
Biology
mouse
Science & Technology
General Immunology and Microbiology
receptor negative allosteric modulator
615 - Farmacologia. Terapèutica. Toxicologia. Radiologia
Neurosciences
pain neuraxis
medicine.disease
optopharmacology
mGlu5 receptor
neuroscience (all)
immunology and microbiology (all)
biochemistry
genetics and molecular biology (all)

MICE
030104 developmental biology
Metabotropic receptor
Mice (Laboratory animals)
RAT
030217 neurology & neurosurgery
Dolor--Tractament
Zdroj: Dipòsit Digital de la UB
Universidad de Barcelona
RECERCAT (Dipòsit de la Recerca de Catalunya)
Recercat. Dipósit de la Recerca de Catalunya
instname
eLife, Vol 6 (2017)
eLife
eLife, 2017, 6, ⟨10.7554/elife.23545.001⟩
ResearcherID
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Digital.CSIC. Repositorio Institucional del CSIC
ISSN: 2050-084X
DOI: 10.7554/elife.23545.001⟩
Popis: Light-operated drugs constitute a major target in drug discovery, since they may provide spatiotemporal resolution for the treatment of complex diseases (i.e. chronic pain). JF-NP-26 is an inactive photocaged derivative of the metabotropic glutamate type 5 (mGlu5) receptor negative allosteric modulator raseglurant. Violet light illumination of JF-NP-26 induces a photochemical reaction prompting the active-drug’s release, which effectively controls mGlu5 receptor activity both in ectopic expressing systems and in striatal primary neurons. Systemic administration in mice followed by local light-emitting diode (LED)-based illumination, either of the thalamus or the peripheral tissues, induced JF-NP-26-mediated light-dependent analgesia both in neuropathic and in acute/tonic inflammatory pain models. These data offer the first example of optical control of analgesia in vivo using a photocaged mGlu5 receptor negative allosteric modulator. This approach shows potential for precisely targeting, in time and space, endogenous receptors, which may allow a better management of difficult-to-treat disorders. © Font et al.
This work was supported by MINECO/ISCIII (SAF2014-55700-P, PCIN-2013–019 C03-03 and PIE14/ 00034), the Catalan Government (2014 SGR 1054), ICREA (ICREA Academia-2010), Fundació la Marató de TV3 (Grant 20152031) and IWT (SBO-140028) to FC. MINECO (PCIN-2013–018 C03-02 and SAF2014-58396-R) to JG. MINECO (PCIN-2013–017 C03-01 and CTQ2014-57020-R), the Catalan Government (2014SGR109 and 2014CTP0002) to AL. ERANET Neuron project ‘LIGHTPAIN’ (to AL, JG, PC and FN). MINECO (CTQ2013-48767-C3-1-R and CTQ2015-71896-REDT), the Catalan Government (2014SGR304) to SN RB-O thanks the European Social Funds and the SUR del DEC de la Generalitat de Catalunya for a predoctoral fellowship (2016 FI_B1 00021).
Databáze: OpenAIRE